Azaindole derivatives and their use as ERK kinase inhibitors
The present invention concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity in particular ERK2 activity, it also concerns prodrugs of these compounds.
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Labesse, Gilles Mathieu, Loic Bories, Cédric Guichou, Jean-François Gelin, Muriel Geoffroy, Clément Bessin, Yannick Duquenne, Charline |
description | The present invention concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity in particular ERK2 activity, it also concerns prodrugs of these compounds. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US11708364B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US11708364B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US11708364B23</originalsourceid><addsrcrecordid>eNrjZLBxrErMzEvJz0lVSEktyixLLMksSy1WSMxLUSjJSM0sUigtTlVILFZwDfJWyM7MSwTyMvMyMpMyS_KLinkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGhuYGFsZmJk5ExMWoAwykvmA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Azaindole derivatives and their use as ERK kinase inhibitors</title><source>esp@cenet</source><creator>Labesse, Gilles ; Mathieu, Loic ; Bories, Cédric ; Guichou, Jean-François ; Gelin, Muriel ; Geoffroy, Clément ; Bessin, Yannick ; Duquenne, Charline</creator><creatorcontrib>Labesse, Gilles ; Mathieu, Loic ; Bories, Cédric ; Guichou, Jean-François ; Gelin, Muriel ; Geoffroy, Clément ; Bessin, Yannick ; Duquenne, Charline</creatorcontrib><description>The present invention concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity in particular ERK2 activity, it also concerns prodrugs of these compounds.</description><language>eng</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230725&DB=EPODOC&CC=US&NR=11708364B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230725&DB=EPODOC&CC=US&NR=11708364B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Labesse, Gilles</creatorcontrib><creatorcontrib>Mathieu, Loic</creatorcontrib><creatorcontrib>Bories, Cédric</creatorcontrib><creatorcontrib>Guichou, Jean-François</creatorcontrib><creatorcontrib>Gelin, Muriel</creatorcontrib><creatorcontrib>Geoffroy, Clément</creatorcontrib><creatorcontrib>Bessin, Yannick</creatorcontrib><creatorcontrib>Duquenne, Charline</creatorcontrib><title>Azaindole derivatives and their use as ERK kinase inhibitors</title><description>The present invention concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity in particular ERK2 activity, it also concerns prodrugs of these compounds.</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBxrErMzEvJz0lVSEktyixLLMksSy1WSMxLUSjJSM0sUigtTlVILFZwDfJWyM7MSwTyMvMyMpMyS_KLinkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxosKGhuYGFsZmJk5ExMWoAwykvmA</recordid><startdate>20230725</startdate><enddate>20230725</enddate><creator>Labesse, Gilles</creator><creator>Mathieu, Loic</creator><creator>Bories, Cédric</creator><creator>Guichou, Jean-François</creator><creator>Gelin, Muriel</creator><creator>Geoffroy, Clément</creator><creator>Bessin, Yannick</creator><creator>Duquenne, Charline</creator><scope>EVB</scope></search><sort><creationdate>20230725</creationdate><title>Azaindole derivatives and their use as ERK kinase inhibitors</title><author>Labesse, Gilles ; Mathieu, Loic ; Bories, Cédric ; Guichou, Jean-François ; Gelin, Muriel ; Geoffroy, Clément ; Bessin, Yannick ; Duquenne, Charline</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US11708364B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Labesse, Gilles</creatorcontrib><creatorcontrib>Mathieu, Loic</creatorcontrib><creatorcontrib>Bories, Cédric</creatorcontrib><creatorcontrib>Guichou, Jean-François</creatorcontrib><creatorcontrib>Gelin, Muriel</creatorcontrib><creatorcontrib>Geoffroy, Clément</creatorcontrib><creatorcontrib>Bessin, Yannick</creatorcontrib><creatorcontrib>Duquenne, Charline</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Labesse, Gilles</au><au>Mathieu, Loic</au><au>Bories, Cédric</au><au>Guichou, Jean-François</au><au>Gelin, Muriel</au><au>Geoffroy, Clément</au><au>Bessin, Yannick</au><au>Duquenne, Charline</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Azaindole derivatives and their use as ERK kinase inhibitors</title><date>2023-07-25</date><risdate>2023</risdate><abstract>The present invention concerns a compound of formula (I), or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the ERK kinase activity in particular ERK2 activity, it also concerns prodrugs of these compounds.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US11708364B2 |
source | esp@cenet |
subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Azaindole derivatives and their use as ERK kinase inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T05%3A20%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Labesse,%20Gilles&rft.date=2023-07-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS11708364B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |